Science fiction has become reality: Best practice for future viral pandemics.
作者信息
Wright Daniel F B, Kirkpatrick Carl M J
机构信息
School of Pharmacy, University of Otago, Dunedin, New Zealand.
Centre for Medicine Use and Safety, Monash University, Melbourne, Australia.
出版信息
Br J Clin Pharmacol. 2021 Sep;87(9):3385-3387. doi: 10.1111/bcp.14997. Epub 2021 Aug 2.
Abstract
摘要
相似文献
1
Science fiction has become reality: Best practice for future viral pandemics.科幻已成为现实：未来病毒性大流行的最佳实践。
Br J Clin Pharmacol. 2021 Sep;87(9):3385-3387. doi: 10.1111/bcp.14997. Epub 2021 Aug 2.
2
New ways: the pandemics of science fiction.新途径：科幻小说中的大流行病。
Interface Focus. 2021 Oct 12;11(6):20210027. doi: 10.1098/rsfs.2021.0027. eCollection 2021 Dec 6.
3
Pandemics, epidemics, viruses, plagues, and disease: Comparative frequency analysis of a cultural pathology reflected in science fiction magazines from 1926 to 2015.大流行、流行病、病毒、瘟疫与疾病：对1926年至2015年科幻杂志中所反映的一种文化病理学的比较频率分析
Soc Sci Humanit Open. 2020;2(1):100048. doi: 10.1016/j.ssaho.2020.100048. Epub 2020 Sep 9.
4
Universal influenza vaccines, science fiction or soon reality?通用流感疫苗，是科幻小说还是即将成为现实？
Expert Rev Vaccines. 2015;14(10):1299-301. doi: 10.1586/14760584.2015.1060860. Epub 2015 Jun 23.
5
Industry 4.0: Reality, Future or just Science Fiction? How to Convince Today's Management to Invest in Tomorrow's Future! Successful Strategies for Industry 4.0 and Manufacturing IT.工业4.0：现实、未来还是仅仅是科幻小说？如何说服当今的管理层投资于明日的未来！工业4.0与制造业信息技术的成功策略。
Chimia (Aarau). 2016;70(9):628-33. doi: 10.2533/chimia.2016.628.
6
Science fiction and the medical humanities.科幻小说与医学人文学科。
Med Humanit. 2016 Dec;42(4):213-218. doi: 10.1136/medhum-2016-011144.
7
What we may learn - and need - from pandemic fiction.我们可以从大流行题材小说中学到什么——以及需要学到什么。
Philos Ethics Humanit Med. 2020 Jul 21;15(1):4. doi: 10.1186/s13010-020-00089-0.
8
Memory editing from science fiction to clinical practice.从科幻小说到临床实践的记忆编辑。
Nature. 2019 Aug;572(7767):43-50. doi: 10.1038/s41586-019-1433-7. Epub 2019 Jul 31.
9
Utilizing the Learning Health System Adaptation to guide Family Medicine Practice to COVID-19 response.利用学习型健康系统适应模式指导家庭医学实践应对新冠肺炎疫情。
J Prim Care Community Health. 2020 Jan-Dec;11:2150132720966409. doi: 10.1177/2150132720966409.
10
[Avian influenza pandemics: reality or fiction?].[禽流感大流行：现实还是虚构？]
Farm Hosp. 2006 Jul-Aug;30(4):206-8. doi: 10.1016/s1130-6343(06)73976-9.
本文引用的文献
1
Development, evaluation and use of COVID-19 vaccines in older adults: Preliminary principles for the pandemic and beyond.老年人中新冠病毒疫苗的研发、评估与使用：大流行期间及之后的初步原则
Br J Clin Pharmacol. 2021 Sep;87(9):3459-3461. doi: 10.1111/bcp.14967. Epub 2021 Aug 2.
2
Traditional medicines for COVID-19: Perspectives from clinical pharmacologists.传统医学治疗 COVID-19：临床药理学家的观点。
Br J Clin Pharmacol. 2021 Sep;87(9):3455-3458. doi: 10.1111/bcp.14981. Epub 2021 Jul 16.
3
Pandemics, epidemics, viruses, plagues, and disease: Comparative frequency analysis of a cultural pathology reflected in science fiction magazines from 1926 to 2015.大流行、流行病、病毒、瘟疫与疾病：对1926年至2015年科幻杂志中所反映的一种文化病理学的比较频率分析
Soc Sci Humanit Open. 2020;2(1):100048. doi: 10.1016/j.ssaho.2020.100048. Epub 2020 Sep 9.
4
Blueprint for pandemic response: Focus on translational medicine, clinical pharmacology and pharmacometrics.大流行应对计划蓝图：关注转化医学、临床药理学和临床药代动力学。
Br J Clin Pharmacol. 2021 Sep;87(9):3398-3407. doi: 10.1111/bcp.14859. Epub 2021 May 6.
5
Model-informed drug repurposing: A pharmacometric approach to novel pathogen preparedness, response and retrospection.基于模型的药物重定位：一种新病原体防备、应对和回顾的药物计量学方法。
Br J Clin Pharmacol. 2021 Sep;87(9):3388-3397. doi: 10.1111/bcp.14760. Epub 2021 Feb 23.
6
Using in silico viral kinetic models to guide therapeutic strategies during a pandemic: An example in SARS-CoV-2.利用计算机病毒动力学模型指导大流行期间的治疗策略：以 SARS-CoV-2 为例。
Br J Clin Pharmacol. 2021 Sep;87(9):3425-3438. doi: 10.1111/bcp.14718. Epub 2021 Jan 15.
7
Racing to immunity: Journey to a COVID-19 vaccine and lessons for the future.争分夺秒获得免疫力：新冠病毒疫苗研发之旅及未来的经验教训。
Br J Clin Pharmacol. 2021 Sep;87(9):3408-3424. doi: 10.1111/bcp.14686. Epub 2021 Jan 6.
8
Risk assessment of therapeutic agents under consideration to treat COVID-19 in paediatric patients and pregnant women.治疗 COVID-19 儿科患者和孕妇药物的风险评估。
Br J Clin Pharmacol. 2021 Sep;87(9):3462-3480. doi: 10.1111/bcp.14630. Epub 2020 Nov 28.
9
Model-informed drug repurposing: Viral kinetic modelling to prioritize rational drug combinations for COVID-19.基于模型的药物再利用：病毒动力学模型优化 COVID-19 的合理药物组合。
Br J Clin Pharmacol. 2021 Sep;87(9):3439-3450. doi: 10.1111/bcp.14486. Epub 2020 Aug 5.
10
The impact of the global COVID-19 pandemic on the conduct of clinical trials: Return to normalcy by considering the practical impact of a structured ethical analysis.全球 COVID-19 大流行对临床试验开展的影响：通过考虑结构化伦理分析的实际影响，回归常态。
Br J Clin Pharmacol. 2021 Mar;87(3):837-844. doi: 10.1111/bcp.14480. Epub 2020 Jul 26.
Zotero 插件